A citation-based method for searching scientific literature

Aikaterini Thanou, Joan T Merrill. Curr Rheumatol Rep 2018
Times Cited: 7







List of co-cited articles
16 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.
Richard Furie, Munther Khamashta, Joan T Merrill, Victoria P Werth, Kenneth Kalunian, Philip Brohawn, Gabor G Illei, Jorn Drappa, Liangwei Wang, Stephen Yoo. Arthritis Rheumatol 2017
351
42



Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.
Megan E B Clowse, Daniel J Wallace, Richard A Furie, Michelle A Petri, Marilyn C Pike, Piotr Leszczyński, C Michael Neuwelt, Kathryn Hobbs, Mauro Keiserman, Liliana Duca,[...]. Arthritis Rheumatol 2017
91
28

Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study.
William Stohl, Andreas Schwarting, Masato Okada, Morton Scheinberg, Andrea Doria, Anne E Hammer, Christi Kleoudis, James Groark, Damon Bass, Norma Lynn Fox,[...]. Arthritis Rheumatol 2017
119
28

A critical review of clinical trials in systemic lupus erythematosus.
M A Mahieu, V Strand, L S Simon, P E Lipsky, R Ramsey-Goldman. Lupus 2016
35
28

Development and Validation of a Novel Evidence-Based Lupus Multivariable Outcome Score for Clinical Trials.
Michal Abrahamowicz, John M Esdaile, Rosalind Ramsey-Goldman, Lee S Simon, Vibeke Strand, Peter E Lipsky. Arthritis Rheumatol 2018
7
28

Assay variation in the detection of antinuclear antibodies in the sera of patients with established SLE.
David S Pisetsky, Diane M Spencer, Peter E Lipsky, Brad H Rovin. Ann Rheum Dis 2018
69
28


A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).
Kenneth C Kalunian, Joan T Merrill, Romeo Maciuca, Jacqueline M McBride, Michael J Townsend, Xiaohui Wei, John C Davis, William P Kennedy. Ann Rheum Dis 2016
202
28

JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects.
Shubhasree Banerjee, Ann Biehl, Massimo Gadina, Sarfaraz Hasni, Daniella M Schwartz. Drugs 2017
254
28

Type I interferon correlates with serological and clinical manifestations of SLE.
M C Dall'era, P M Cardarelli, B T Preston, A Witte, J C Davis. Ann Rheum Dis 2005
191
28

Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab.
Robert W Hoffman, Joan T Merrill, Marta M E Alarcón-Riquelme, Michelle Petri, Ernst R Dow, Eric Nantz, Laura K Nisenbaum, Krista M Schroeder, Wendy J Komocsar, Narayanan B Perumal,[...]. Arthritis Rheumatol 2017
28
28

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.
Emily C Baechler, Franak M Batliwalla, George Karypis, Patrick M Gaffney, Ward A Ortmann, Karl J Espe, Katherine B Shark, William J Grande, Karis M Hughes, Vivek Kapur,[...]. Proc Natl Acad Sci U S A 2003
28

High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus.
T B Niewold, J Hua, T J A Lehman, J B Harley, M K Crow. Genes Immun 2007
281
28

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.
Lynda Bennett, A Karolina Palucka, Edsel Arce, Victoria Cantrell, Josef Borvak, Jacques Banchereau, Virginia Pascual. J Exp Med 2003
28

The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.
Eoghan M McCarthy, Emily Sutton, Stephanie Nesbit, Ben Parker, David Jayne, Bridget Griffiths, David A Isenberg, Anisur Rahman, Caroline Gordon, David P D'Cruz,[...]. Rheumatology (Oxford) 2017
3
33

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults.
Caroline Gordon, Maame-Boatemaa Amissah-Arthur, Mary Gayed, Sue Brown, Ian N Bruce, David D'Cruz, Benjamin Empson, Bridget Griffiths, David Jayne, Munther Khamashta,[...]. Rheumatology (Oxford) 2018
103
14

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response.
Ronald F van Vollenhoven, Michelle A Petri, Ricard Cervera, David A Roth, Beulah N Ji, Christi S Kleoudis, Z John Zhong, William Freimuth. Ann Rheum Dis 2012
227
14

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Sandra V Navarra, Renato M Guzmán, Alberto E Gallacher, Stephen Hall, Roger A Levy, Renato E Jimenez, Edmund K-M Li, Mathew Thomas, Ho-Youn Kim, Manuel G León,[...]. Lancet 2011
985
14

From BILAG to BILAG-based combined lupus assessment-30 years on.
Claire-Louise Murphy, Chee-Seng Yee, Caroline Gordon, David Isenberg. Rheumatology (Oxford) 2016
5
20

Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study.
Daniel J Wallace, Kenneth Kalunian, Michelle A Petri, Vibeke Strand, Frederic A Houssiau, Marilyn Pike, Brian Kilgallen, Sabine Bongardt, Anna Barry, Lexy Kelley,[...]. Ann Rheum Dis 2014
177
14

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
Ian N Bruce, Aidan G O'Keeffe, Vern Farewell, John G Hanly, Susan Manzi, Li Su, Dafna D Gladman, Sang-Cheol Bae, Jorge Sanchez-Guerrero, Juanita Romero-Diaz,[...]. Ann Rheum Dis 2015
215
14

Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register.
Eoghan M McCarthy, Emily Sutton, Stephanie Nesbit, James White, Ben Parker, David Jayne, Bridget Griffiths, David A Isenberg, Anisur Rahman, Caroline Gordon,[...]. Rheumatology (Oxford) 2018
36
14

Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort.
Jayne Little, Ben Parker, Mark Lunt, John G Hanly, Murray B Urowitz, Ann E Clarke, Juanita Romero-Diaz, Caroline Gordon, Sang-Cheol Bae, Sasha Bernatsky,[...]. Rheumatology (Oxford) 2018
17
14

The Incidence and Prevalence of Systemic Lupus Erythematosus in San Francisco County, California: The California Lupus Surveillance Project.
Maria Dall'Era, Miriam G Cisternas, Kurt Snipes, Lisa J Herrinton, Caroline Gordon, Charles G Helmick. Arthritis Rheumatol 2017
64
14

Sensitivity to Change and Minimal Important Differences of the LupusQoL in Patients With Systemic Lupus Erythematosus.
Kathleen McElhone, Janice Abbott, Chris Sutton, Montana Mullen, Peter Lanyon, Anisur Rahman, Chee-Seng Yee, Mohammed Akil, Ian N Bruce, Yasmeen Ahmad,[...]. Arthritis Care Res (Hoboken) 2016
25
14

Performance of Antinuclear Antibodies for Classifying Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Regression of Diagnostic Data.
Nicolai Leuchten, Annika Hoyer, Ralph Brinks, Monika Schoels, Matthias Schneider, Josef Smolen, Sindhu R Johnson, David Daikh, Thomas Dörner, Martin Aringer,[...]. Arthritis Care Res (Hoboken) 2018
57
14

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.
Daniel J Wallace, William Stohl, Richard A Furie, Jeffrey R Lisse, James D McKay, Joan T Merrill, Michelle A Petri, Ellen M Ginzler, W Winn Chatham, W Joseph McCune,[...]. Arthritis Rheum 2009
352
14


Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.
Mary Anne Dooley, David Jayne, Ellen M Ginzler, David Isenberg, Nancy J Olsen, David Wofsy, Frank Eitner, Gerald B Appel, Gabriel Contreras, Laura Lisk,[...]. N Engl J Med 2011
331
14

Moving towards a molecular taxonomy of autoimmune rheumatic diseases.
Guillermo Barturen, Lorenzo Beretta, Ricard Cervera, Ronald Van Vollenhoven, Marta E Alarcón-Riquelme. Nat Rev Rheumatol 2018
36
14

Can we identify who gets benefit or harm from mycophenolate mofetil in systemic lupus erythematosus? A systematic review.
Claudia Mendoza-Pinto, Carmelo Pirone, Daniëlle A van der Windt, Ben Parker, Ian N Bruce. Semin Arthritis Rheum 2017
7
14

Defining Low Disease Activity in Systemic Lupus Erythematosus.
Ari Polachek, Dafna D Gladman, Jiandong Su, Murray B Urowitz. Arthritis Care Res (Hoboken) 2017
35
14

Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III study.
Eduardo F Mysler, Alberto J Spindler, Renato Guzman, Marc Bijl, David Jayne, Richard A Furie, Frédéric A Houssiau, Jorn Drappa, David Close, Romeo Maciuca,[...]. Arthritis Rheum 2013
165
14

Hurdles to the introduction of new therapies for immune-mediated kidney diseases.
Hans-Joachim Anders, David R W Jayne, Brad H Rovin. Nat Rev Nephrol 2016
32
14

Prevalence and incidence of systemic lupus erythematosus in a population-based registry of American Indian and Alaska Native people, 2007-2009.
Elizabeth D Ferucci, Janet M Johnston, Jasmine R Gaddy, Lisa Sumner, James O Posever, Tammy L Choromanski, Caroline Gordon, S Sam Lim, Charles G Helmick. Arthritis Rheumatol 2014
59
14

Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study.
David Isenberg, Gerald B Appel, Gabriel Contreras, Mary A Dooley, Ellen M Ginzler, David Jayne, Jorge Sánchez-Guerrero, David Wofsy, Xueqing Yu, Neil Solomons. Rheumatology (Oxford) 2010
183
14


American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.
Bevra H Hahn, Maureen A McMahon, Alan Wilkinson, W Dean Wallace, David I Daikh, John D Fitzgerald, George A Karpouzas, Joan T Merrill, Daniel J Wallace, Jinoos Yazdany,[...]. Arthritis Care Res (Hoboken) 2012
715
14


Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program.
Emily C Somers, Wendy Marder, Patricia Cagnoli, Emily E Lewis, Peter DeGuire, Caroline Gordon, Charles G Helmick, Lu Wang, Jeffrey J Wing, J Patricia Dhar,[...]. Arthritis Rheumatol 2014
223
14

The incidence and prevalence of systemic lupus erythematosus, 2002-2004: The Georgia Lupus Registry.
S Sam Lim, A Rana Bayakly, Charles G Helmick, Caroline Gordon, Kirk A Easley, Cristina Drenkard. Arthritis Rheumatol 2014
181
14

A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS).
Ronald van Vollenhoven, Alexandre Voskuyl, George Bertsias, Cynthia Aranow, Martin Aringer, Laurent Arnaud, Anca Askanase, Petra Balážová, Eloisa Bonfa, Hendrika Bootsma,[...]. Ann Rheum Dis 2017
139
14


Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial.
Daniel J Wallace, Vibeke Strand, Joan T Merrill, Serghei Popa, Alberto J Spindler, Alicia Eimon, Michelle Petri, Josef S Smolen, Joseph Wajdula, Jared Christensen,[...]. Ann Rheum Dis 2017
52
14

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
Ellen M Ginzler, Mary Anne Dooley, Cynthia Aranow, Mimi Y Kim, Jill Buyon, Joan T Merrill, Michelle Petri, Gary S Gilkeson, Daniel J Wallace, Michael H Weisman,[...]. N Engl J Med 2005
688
14

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.
Gerald B Appel, Gabriel Contreras, Mary Anne Dooley, Ellen M Ginzler, David Isenberg, David Jayne, Lei-Shi Li, Eduardo Mysler, Jorge Sánchez-Guerrero, Neil Solomons,[...]. J Am Soc Nephrol 2009
589
14

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
Joan T Merrill, C Michael Neuwelt, Daniel J Wallace, Joseph C Shanahan, Kevin M Latinis, James C Oates, Tammy O Utset, Caroline Gordon, David A Isenberg, Hsin-Ju Hsieh,[...]. Arthritis Rheum 2010
716
14



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.